Timing is everything: new trial aims to Fine-Tune cancer treatment
NCT ID NCT07388836
Summary
This study is for people with advanced nasopharyngeal cancer. It aims to find the best day to add an immunotherapy drug (toripalimab) to standard chemotherapy before radiation. Researchers will compare giving the drug on Day 1, Day 5, or Day 9 of the chemo cycle to see which timing leads to the best results and fewest side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.